Filing Flows › Jaguar Health (JAGX) › Q2 2026 › vs Q1 2026
Jaguar Health (JAGX) Q2 2026 vs Q1 2026 (quarter over quarter)
Jaguar Health's revenue fell $19.0M (-94%) from $20.3M in Q1 2026 to $1.2M in Q2 2026.
Jaguar Health, Q2 2026: revenue $1.2M (-59% year over year), operating margin -620.2%, net loss $12.8M, operating cash flow −$5.3M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $1.2M | $20.3M | −$19.0M | -94% |
| Net loss | $12.8M | −$8.7M | $21.5M | — |
| Costs & expenses | $14.0M | $20.3M | −$6.2M | -31% |
| Operating costs | $8.8M | $10.1M | −$1.3M | -13% |
| Interest & other, net | $5.2M | $1.5M | $3.7M | +257% |
| Cost of revenue | $1.0M | $1.2M | −$127K | -11% |
| Research & development | $3.3M | $3.9M | −$592K | -15% |
| Sales & marketing | $5K | $896K | −$891K | -99% |
| General & admin | $4.5M | $4.1M | $342K | +8% |
| Operating cash sources | $12.8M | −$8.7M | $21.5M | — |
| Depreciation & amortization | $473K | $473K | $0 | 0% |
| Share-based compensation | $171K | $155K | $16K | +10% |
| Working capital & other | $6.8M | −$521K | $7.3M | — |
| Cash used in operations | $5.3M | −$8.8M | $14.2M | — |
| Net loss absorbed | $12.8M | −$8.7M | $21.5M | — |
Questions
How much did Jaguar Health's revenue grow quarter over quarter in Q2 2026?
Jaguar Health's revenue fell $19.0M (-94%) from $20.3M in Q1 2026 to $1.2M in Q2 2026.